Stock Comparison
JNJ vs NVS
Johnson & Johnson and Novartis AG ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$613.02B
$296.54B
P/E (TTM)
29.5
22.3
Forward P/E
22.0
17.6
Price/Sales
6.4
5.2
Price/Book
7.6
7.7
EV/EBITDA
19.2
15.1
Dividend Yield
2.12%
3.05%
Profitability
Net Margin
21.80%
23.90%
Operating Margin
27.40%
30.50%
Return on Equity
26.40%
34.90%
Return on Assets
8.42%
10.50%
Growth (YoY)
Revenue Growth
9.90%
-0.70%
Earnings Growth
-52.90%
-9.30%
Price & Risk
Beta
0.3
0.5
52-Week High
$255.11
$165.43
52-Week Low
$147.81
$109.02
Analyst Target
$257.32
$153.87
Compare JNJ and NVS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.